The Connection Between Insulin and Blood Pressure

Insulin does far more than manage blood sugar. It directly influences blood vessel tone, sodium balance in the kidneys, and the activity of the nervous system, all of which feed into blood pressure regulation. When insulin signaling works well, it helps keep arteries relaxed and blood pressure in check. When it doesn’t, the same pathways that fail to handle glucose properly also push blood pressure upward. This dual role makes insulin resistance one of the most underappreciated drivers of high blood pressure, and it helps explain why diabetes and hypertension so frequently travel together.

How Insulin Keeps Blood Vessels Relaxed

Insulin’s most direct effect on blood pressure runs through the inner lining of your blood vessels, the endothelium. When insulin binds to receptors on endothelial cells, it triggers the production of nitric oxide, a molecule that signals the surrounding smooth muscle to relax. That relaxation widens the vessel, lowers resistance to blood flow, and pulls blood pressure down. The same process increases blood flow to skeletal muscle, which helps your tissues take up glucose more efficiently.¹ Research in healthy people has confirmed that the ability to produce nitric oxide and the ability to respond to insulin track together: the more insulin-sensitive someone is, the better their endothelial nitric oxide production tends to be.²

But insulin doesn’t only relax vessels. It also stimulates the release of endothelin-1, a potent vessel-constricting molecule, along with reactive oxygen species. In a healthy person, the balance tips toward relaxation because the nitric oxide pathway dominates.³ Think of it as a tug-of-war between vasodilation and vasoconstriction, with insulin normally pulling the rope toward the relaxation side. Problems start when that balance shifts.

What Happens When Insulin Resistance Tips the Balance

Insulin resistance doesn’t shut down all of insulin’s effects equally. It selectively impairs the signaling branch that produces nitric oxide while leaving the branch that produces endothelin-1 largely intact. The result: less vessel relaxation, more vessel constriction, and a net rise in blood pressure.⁴ This pathway-selective impairment has been confirmed in computational models showing that conditions like high blood sugar, excess circulating fats, and chronic low-grade inflammation all blunt nitric oxide production while boosting endothelin-1 secretion.⁵

The relationship is reciprocal, which makes it especially hard to break. Endothelial dysfunction reduces blood flow to muscle, which worsens insulin resistance. Worsening insulin resistance further impairs the endothelium. The two conditions feed off each other in a loop that, left unchecked, accelerates both high blood pressure and metabolic disease.⁶

Insulin Tells Your Kidneys to Hold On to Sodium

Your kidneys filter and reabsorb sodium all day long, and insulin has a surprisingly large say in how much sodium gets kept versus how much gets flushed out. Multiple sodium transporters along the kidney tubule are regulated by insulin, including the channels in the proximal tubule and the epithelial sodium channel (ENaC) in the collecting duct.⁷ When insulin levels rise, those transporters ramp up activity, pulling more sodium back into the bloodstream. More sodium means more water retention, which expands blood volume and raises blood pressure.

Animal studies have made this effect strikingly clear. When rats received chronic insulin infusions, the activity of key sodium-reabsorbing channels in the kidney increased substantially, and blood pressure went up alongside.⁸ This mechanism is particularly relevant for people with insulin resistance, because their pancreas pumps out extra insulin to compensate for sluggish cellular responses. That chronically elevated insulin keeps telling the kidneys to retain sodium even when the body doesn’t need it.

The Sympathetic Nervous System Gets Revved Up

Insulin also activates the sympathetic nervous system, the “fight or flight” branch that, among other things, speeds up the heart and constricts blood vessels. Studies measuring nerve activity directly in humans found that even a normal rise in insulin after a meal increases sympathetic nerve firing. In one study of people with borderline high blood pressure, sympathetic nerve activity jumped by about nine extra bursts per minute during insulin infusion and stayed elevated even after insulin levels began to drop.⁹

An interesting wrinkle: in that same study, the acute rise in sympathetic tone did not immediately raise blood pressure, because insulin’s vasodilating effects through nitric oxide counterbalanced the nerve-driven constriction. In a healthy person, those forces roughly cancel out. But in someone whose nitric oxide pathway is already impaired by insulin resistance, the sympathetic push no longer has an adequate counterweight. That is when chronically elevated insulin starts to translate directly into higher resting blood pressure.

Insulin’s Cross-Talk with the Renin-Angiotensin System

There is yet another route by which insulin can raise blood pressure: the renin-angiotensin-aldosterone system, the hormonal cascade that regulates blood volume and vessel tone. Elevated insulin can activate this system at the tissue level, promoting the production of angiotensin II and aldosterone in blood vessels, the heart, and fat tissue.¹⁰ Angiotensin II constricts blood vessels and prompts the kidneys to retain even more sodium, compounding the effects described earlier. This cross-talk provides a mechanistic link between metabolic syndrome, hyperinsulinemia, and hypertension that goes beyond any single pathway.

What the Clinical Data Actually Show

The biological mechanisms are compelling, but you might reasonably ask whether insulin resistance truly predicts high blood pressure in real people. It does. A large study in healthy, nondiabetic Europeans found that both systolic and diastolic blood pressure were inversely related to insulin sensitivity, even after accounting for sex, age, and body mass. Strikingly, the impact of becoming more insulin resistant was similar in magnitude to aging by a decade: a meaningful drop in insulin sensitivity predicted about a 1.4 mmHg rise in blood pressure, roughly the same as being ten years older.¹¹ Body weight itself was not an independent predictor once insulin sensitivity was accounted for, suggesting that the metabolic dysfunction matters more than the weight per se.

The association holds even in people who aren’t overweight. A study of normal-weight Chinese adults found that those in the highest quartile of an insulin resistance index had roughly double to triple the odds of having hypertension compared with those in the lowest quartile, after adjusting for other risk factors.¹² This finding pushes back against the common assumption that insulin resistance is only a concern for people carrying excess weight.

How Blood Pressure Medications Affect Insulin Sensitivity

The connection between insulin and blood pressure has practical consequences for choosing blood pressure medications. Not all classes of antihypertensives treat the underlying metabolic picture the same way. Older classes like thiazide diuretics and beta-blockers can actually worsen insulin resistance and disturb blood lipids, which may partly explain why early hypertension trials found disappointing reductions in heart disease despite successfully lowering blood pressure numbers.¹³ Certain cardiovascular drugs, including some diuretics, beta-blockers, calcium channel blockers, and statins, have been linked to glycemic disturbances through effects on insulin secretion, insulin sensitivity, or direct stress on the cells that produce insulin.¹⁴

By contrast, ACE inhibitors and angiotensin receptor blockers tend to be metabolically neutral or even mildly beneficial. One study found that losartan, an angiotensin receptor blocker, had no adverse effect on insulin sensitivity, glucose tolerance, or lipid levels after 12 weeks of treatment in people with hypertension.¹⁵ For someone who is insulin resistant and also has high blood pressure, these differences can shape which medication makes the most sense. Treating the blood pressure number while worsening the metabolic environment is a bit like patching one leak while opening another.

Diabetes Drugs That Also Lower Blood Pressure

The flip side of the coin is equally interesting: medications designed to improve insulin sensitivity or glucose control often bring blood pressure down as a side benefit. Thiazolidinediones, a class of insulin-sensitizing drugs, modestly lower blood pressure in addition to their glucose effects. A meta-analysis found they reduced systolic blood pressure by about 3.5 mmHg and diastolic by about 1.8 mmHg compared with placebo.¹⁶ The reductions are small and unlikely to replace blood pressure drugs, but they point to the shared biology underneath both conditions.¹⁷

Newer drug classes have strengthened this picture further. SGLT2 inhibitors and GLP-1 receptor agonists, originally developed for glucose and weight management, consistently lower blood pressure across a wide range of patient populations, including people who don’t have diabetes. The blood pressure reductions appear largely independent of how well the drugs control blood sugar, suggesting they work through mechanisms like sodium excretion, weight loss, and improved vascular function rather than simply fixing glucose numbers.¹⁸ These drugs have increasingly been used in cardiology and nephrology settings specifically for their vascular and renal protective effects, not just glucose control.

Lifestyle Changes That Address Both Problems at Once

Because insulin and blood pressure share so much underlying biology, lifestyle interventions that improve insulin sensitivity tend to lower blood pressure as well. A primary care study of insulin-resistant patients placed on a carbohydrate-restricted diet reported sustained improvements in blood pressure, with the authors attributing the effect at least partly to reduced insulin levels and improved insulin sensitivity. Lowering circulating insulin would be expected to reduce sodium retention and shift the vascular tug-of-war back toward relaxation.¹⁹ Animal research has supported this: spontaneously hypertensive rats fed a low-carbohydrate, high-fat diet had lower average arterial pressure and lower circulating insulin compared with rats on a standard diet, without developing signs of insulin resistance.²⁰

Exercise works through overlapping channels. Physical activity improves how your muscles take up glucose, lowers circulating insulin, and directly benefits endothelial function. In people with type 2 diabetes, exercise training has been shown to improve markers of insulin sensitivity alongside reductions in circulating markers of endothelial damage.¹⁹ The takeaway is that interventions targeting insulin resistance don’t just help blood sugar; they hit many of the same levers that drive blood pressure.

The Connection in Type 1 Diabetes

The insulin-blood pressure connection is usually discussed in the context of type 2 diabetes and metabolic syndrome, but it applies to type 1 diabetes as well. People with type 1 diabetes can develop insulin resistance too, sometimes called “double diabetes,” and when they do, hypertension follows. In one study of nearly 300 type 1 diabetes patients, about 30% had hypertension. After adjusting for other factors, insulin sensitivity was independently and significantly associated with blood pressure status, with each unit of improvement in insulin sensitivity corresponding to roughly a 6% decrease in the likelihood of having hypertension.²¹

Insulin resistance in type 1 diabetes also accelerates kidney disease, which in turn drives blood pressure even higher. Research from the Pittsburgh Epidemiology of Diabetes Complications Study identified insulin resistance as an underlying risk factor for kidney disease in type 1 diabetes, a risk that hypertension then amplifies.²² Patients with chronic kidney disease and type 1 diabetes show markedly worse insulin resistance compared with those whose kidneys are still intact, along with higher rates of hypertension and dyslipidemia.²³ The message is that insulin resistance and high blood pressure cluster together regardless of the type of diabetes driving the underlying metabolic problem.

The Thrifty Genotype Hypothesis

Why are insulin resistance and high blood pressure so tightly linked at a biological level? One perspective comes from evolutionary biology. For most of human history, food was scarce, sodium was hard to find, and survival depended on storing energy efficiently and hanging on to every grain of salt the body absorbed. Genes that promoted energy storage and sodium retention were advantageous and were passed on. This is sometimes called the “thrifty genotype.” In a modern environment of calorie-dense food, sedentary living, and abundant salt, those same genes become a liability, predisposing people to obesity, insulin resistance, and hypertension simultaneously.²⁴ This framing suggests that the co-occurrence of insulin resistance and high blood pressure isn’t a coincidence or even an unfortunate biological quirk. It may be a package deal, wired into us by millennia of selection pressure, that only becomes a problem when the environment changes faster than our genes can keep up.

Uric Acid as a Shared Warning Sign

If you’ve ever had blood work that flagged elevated uric acid, it may be worth paying attention to both your metabolic health and your blood pressure. Uric acid, commonly associated with gout, is increasingly recognized as a biomarker that travels with insulin resistance. A case-control study found that people who were insulin resistant had a median uric acid level of 5.5 mg/dL compared with 4.6 mg/dL in insulin-sensitive individuals, and uric acid levels correlated positively with measures of insulin resistance.²⁵ High uric acid is also a well-established risk factor for hypertension. The three conditions, elevated uric acid, insulin resistance, and high blood pressure, frequently cluster in the same person, and research in type 1 diabetes confirms that hyperuricemia is significantly more common in those who also have kidney disease and worse insulin resistance.²³ Uric acid isn’t just a gout marker. It may serve as an early, inexpensive flag that the insulin-blood pressure connection is already causing trouble.

When Blood Pressure Doesn’t Dip at Night

In healthy people, blood pressure drops by about 10 to 20 percent during sleep, a pattern called “dipping.” Some people with insulin resistance and diabetes lose this nighttime dip, a pattern associated with worse cardiovascular outcomes. A study of diabetic patients found that non-dippers had nearly four times the odds of moderate-to-severe peripheral nerve damage compared with dippers, even after adjusting for overall blood pressure severity and age.²⁶ The reasons for the loss of the nighttime dip likely involve the same players discussed throughout this article: elevated sympathetic nerve tone, excess sodium retention, and impaired vascular relaxation from endothelial dysfunction. In clinical practice, ambulatory blood pressure monitoring can catch non-dipping patterns that standard office readings miss, giving a more complete picture of cardiovascular risk in people who are insulin resistant.